YVONNE JOLLY: Open Payments
NPI 1982652608 · GENEVA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 34 payments from 13 companies in 2025. Trend: 2023 $1,275 · 2024 $1,573 · 2025 $812
Food & beverage: $812
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $161 |
| BridgeBio Pharma, Inc. | 4 | $130 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $88 |
| Edwards Lifesciences Corporation | 3 | $82 |
| SCPHARMACEUTICALS INC. | 4 | $70 |
| Amgen Inc. | 3 | $49 |
| PFIZER INC. | 3 | $47 |
| Tactile Systems Technology Inc | 1 | $41 |
| Abbott Laboratories | 1 | $39 |
| Boston Scientific Corporation | 1 | $37 |
Products named: Attruby, JARDIANCE, WAINUA, FUROSCIX, FARXIGA, REPATHA, VYNDAQEL, Flexitouch Plus.
Industry payments across NY — which companies pay providers there.
